As of 2025-04-22, the Relative Valuation of 10X Genomics Inc (TXG) is (36.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.68 USD, the upside of 10X Genomics Inc based on Relative Valuation is -580.7%.
The range of the Relative Valuation is (35.13) - (37.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.7x - 28.6x | 25.1x |
| Forward P/E multiples | 22.0x - 25.5x | 24.8x |
| Fair Price | (35.13) - (37.76) | (36.92) |
| Upside | -557.4% - -591.7% | -580.7% |
| Date | P/E |
| 2025-04-17 | -5.08 |
| 2025-04-16 | -5.43 |
| 2025-04-15 | -5.52 |
| 2025-04-14 | -5.59 |
| 2025-04-11 | -5.41 |
| 2025-04-10 | -5.20 |
| 2025-04-09 | -5.86 |
| 2025-04-08 | -4.83 |
| 2025-04-07 | -5.12 |
| 2025-04-04 | -5.05 |
| 2025-04-03 | -5.39 |
| 2025-04-02 | -5.98 |
| 2025-04-01 | -5.86 |
| 2025-03-31 | -5.90 |
| 2025-03-28 | -6.19 |
| 2025-03-27 | -6.36 |
| 2025-03-26 | -6.47 |
| 2025-03-25 | -6.59 |
| 2025-03-24 | -7.02 |
| 2025-03-21 | -7.02 |
| 2025-03-20 | -6.72 |
| 2025-03-19 | -6.95 |
| 2025-03-18 | -7.10 |
| 2025-03-17 | -7.27 |
| 2025-03-14 | -6.99 |
| 2025-03-13 | -6.68 |
| 2025-03-12 | -7.33 |
| 2025-03-11 | -7.31 |
| 2025-03-10 | -7.16 |
| 2025-03-07 | -7.91 |
| 2025-03-06 | -7.75 |
| 2025-03-05 | -7.39 |
| 2025-03-04 | -7.11 |
| 2025-03-03 | -6.66 |
| 2025-02-28 | -7.22 |
| 2025-02-27 | -7.29 |
| 2025-02-26 | -7.87 |
| 2025-02-25 | -7.51 |
| 2025-02-24 | -7.63 |
| 2025-02-21 | -7.37 |
| 2025-02-20 | -7.81 |
| 2025-02-19 | -8.18 |
| 2025-02-18 | -8.16 |
| 2025-02-14 | -8.32 |
| 2025-02-13 | -8.07 |
| 2025-02-12 | -8.11 |
| 2025-02-11 | -7.99 |
| 2025-02-10 | -8.15 |
| 2025-02-07 | -9.63 |
| 2025-02-06 | -9.90 |